Samsara BioCapital, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001744967 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 15, 2026

Total Value: $1.029B (100.0% shares, 0.0% debt)

Holdings (22)

SRRK SCHOLAR ROCK HLDG CORP 32.9%

Value $339M Shares 6,897,652 Est. Cost $14.61 Unrealized +211.2%

MLYS MINERALYS THERAPEUTICS INC 15.5%

Value $159M Shares 5,871,018 Est. Cost $16.38 Unrealized +91.5%

ALMS ALUMIS INC 13.6%

Value $140M Shares 6,345,219 Est. Cost $10.69 Unrealized +127.5%

SEPN SEPTERNA INC 7.4%

Value $75.67M Shares 3,149,128 Est. Cost $22.17 Unrealized +19.6%

KLRS KALARIS THERAPEUTICS INC 7.3%

Value $74.71M Shares 12,948,081 Est. Cost $9.40 Unrealized -0.3%

SGP SPYGLASS PHARMA INC 5.3%

Value $54.67M Shares 2,109,953 Est. Cost $25.91 Unrealized —

NGNE NEUROGENE INC 3.4%

Value $34.62M Shares 1,717,127 Est. Cost $20.31 Unrealized -10.6%

IVA INVENTIVA SA 2.8%

Value $28.83M Shares 5,194,805 Est. Cost $4.65 Unrealized —

STRO SUTRO BIOPHARMA INC 2.6%

Value $26.48M Shares 1,062,872 Est. Cost $14.01 Unrealized +7.7%

JBIO JADE BIOSCIENCES INC 1.3%

Value $13.61M Shares 968,798 Est. Cost $23.56 Unrealized -37.2%

VTVT VTV THERAPEUTICS INC 1.2%

Value $11.84M Shares 298,496 Est. Cost $14.92 Unrealized +142.2%

AQST AQUESTIVE THERAPEUTICS INC 1.0%

Value $10.38M Shares 2,500,000 Est. Cost $4.32 Unrealized -7.0%

XFOR X4 PHARMACEUTICALS INC 0.7%

Value $7.568M Shares 1,832,566 Est. Cost $3.63 Unrealized +0.1%

NKTX NKARTA INC 0.7%

Value $7.401M Shares 3,507,666 Est. Cost $21.30 Unrealized -89.8%

ACLX ARCELLX INC 0.7%

Value $6.989M Shares 60,873 Est. Cost $16.49 Unrealized +332.4%

UPB UPSTREAM BIO INC 0.6%

Value $6.624M Shares 736,047 Est. Cost $22.33 Unrealized +6.1%

ABVX ABIVAX SA 0.6%

Value $6.3M Shares 56,581 Est. Cost $84.90 Unrealized —

AGMB AGOMAB THERAPEUTICS NV 0.6%

Value $6.294M Shares 600,000 Est. Cost $10.49 Unrealized —

RANI RANI THERAPEUTICS HLDGS INC 0.6%

Value $6.246M Shares 8,500,000 Est. Cost $1.51 Unrealized -12.3%

CHRS COHERUS ONCOLOGY INC 0.6%

Value $5.794M Shares 3,428,571 Est. Cost $1.82 Unrealized 0.0%

PVLA PALVELLA THERAPEUTICS INC NE 0.5%

Value $4.791M Shares 38,432 Est. Cost $15.71 Unrealized +481.7%

GOSS GOSSAMER BIO INC 0.2%

Value $2.373M Shares 7,222,559 Est. Cost $1.41 Unrealized +60.1%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
SRRK	SCHOLAR ROCK HLDG CORP	6,897,652	$339M	32.9%	$14.61	+211.2%	COM	80706P103
MLYS	MINERALYS THERAPEUTICS INC	5,871,018	$159M	15.5%	$16.38	+91.5%	COM	603170101
ALMS	ALUMIS INC	6,345,219	$140M	13.6%	$10.69	+127.5%	COM	022307102
SEPN	SEPTERNA INC	3,149,128	$75.67M	7.4%	$22.17	+19.6%	COM	81734D104
KLRS	KALARIS THERAPEUTICS INC	12,948,081	$74.71M	7.3%	$9.40	-0.3%	COM	482929106
SGP	SPYGLASS PHARMA INC	2,109,953	$54.67M	5.3%	$25.91	—	COM SHS	85220G109
NGNE	NEUROGENE INC	1,717,127	$34.62M	3.4%	$20.31	-10.6%	COM	64135M105
IVA	INVENTIVA SA	5,194,805	$28.83M	2.8%	$4.65	—	ADS	46124U107
STRO	SUTRO BIOPHARMA INC	1,062,872	$26.48M	2.6%	$14.01	+7.7%	COM SHS	869367201
JBIO	JADE BIOSCIENCES INC	968,798	$13.61M	1.3%	$23.56	-37.2%	COM NEW	008064206
VTVT	VTV THERAPEUTICS INC	298,496	$11.84M	1.2%	$14.92	+142.2%	CL A NEW	918385204
AQST	AQUESTIVE THERAPEUTICS INC	2,500,000	$10.38M	1.0%	$4.32	-7.0%	COM	03843E104
XFOR	X4 PHARMACEUTICALS INC	1,832,566	$7.568M	0.7%	$3.63	+0.1%	COM NEW	98420X202
NKTX	NKARTA INC	3,507,666	$7.401M	0.7%	$21.30	-89.8%	COM	65487U108
ACLX	ARCELLX INC	60,873	$6.989M	0.7%	$16.49	+332.4%	COMMON STOCK	03940C100
UPB	UPSTREAM BIO INC	736,047	$6.624M	0.6%	$22.33	+6.1%	COM	91678A107
ABVX	ABIVAX SA	56,581	$6.3M	0.6%	$84.90	—	SPONSORED ADS	00370M103
AGMB	AGOMAB THERAPEUTICS NV	600,000	$6.294M	0.6%	$10.49	—	SPONSORED ADS	00860C102
RANI	RANI THERAPEUTICS HLDGS INC	8,500,000	$6.246M	0.6%	$1.51	-12.3%	COM CL A	753018100
CHRS	COHERUS ONCOLOGY INC	3,428,571	$5.794M	0.6%	$1.82	0.0%	COM	19249H103
PVLA	PALVELLA THERAPEUTICS INC NE	38,432	$4.791M	0.5%	$15.71	+481.7%	COM	697947109
GOSS	GOSSAMER BIO INC	7,222,559	$2.373M	0.2%	$1.41	+60.1%	COM	38341P102